INS and asthma: Inspecting the baseline characteristics of participants in those trials (in Table 1 in Nudy 2021 [90]) shows that participants were being studied for various adverse health effects, including arthritis index pain, asthma exacerbations, progression to type 2 DM, falls and fractures, insulin sensitivity, and renal function.